β-D-Glucan kinetics for the assessment of treatment response in Pneumocystis jirovecii pneumonia

被引:36
作者
Held, J. [1 ]
Wagner, D. [2 ,3 ]
机构
[1] Univ Freiburg, Inst Med Microbiol & Hyg, D-79104 Freiburg, Germany
[2] Univ Freiburg, Ctr Infect Dis & Travel Med, D-79104 Freiburg, Germany
[3] Univ Freiburg, Ctr Chron Immunodeficiency, D-79104 Freiburg, Germany
关键词
beta-D-Glucan; follow-up; kinetic; Pneumocystis jirovecii pneumonia; therapy success; INVASIVE FUNGAL-INFECTIONS; EARLY-DIAGNOSIS;
D O I
10.1111/j.1469-0691.2010.03452.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Serum (1 -> 3)-beta-D-Glucan (BG) is a biomarker for Pneumocystis jirovecii pneumonia (PJP). However, information concerning its usefulness for monitoring the clinical course is lacking. We conducted a retrospective study to investigate whether consecutive BG-measurements can be used to assess treatment response in PJP. Analysis of sera from 18 patients during PJP therapy shows that decreasing BG-levels strongly correlate with a favourable clinical course. In contrast, increasing BG-levels were associated with treatment failure or fatal outcome is only 44% of patients. As a consequence, BG-kinetics might be used to confirm treatment success but seem to be of limited value for the identification of treatment failure.
引用
收藏
页码:1118 / 1122
页数:6
相关论文
共 11 条
[1]   The (1,3)β-D-Glucan Test as an Aid to Early Diagnosis of Invasive Fungal Infections following Lung Transplantation [J].
Alexander, Barbara D. ;
Smith, P. Brian ;
Davis, R. Duane ;
Perfect, John R. ;
Reller, L. Barth .
JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (11) :4083-4088
[2]   Serum (1-3)-β-D-Glucan as a Tool for Diagnosis of Pneumocystis jirovecii Pneumonia in Patients with Human Immunodeficiency Virus Infection or Hematological Malignancy [J].
Desmet, Stefanie ;
Van Wijngaerden, Eric ;
Maertens, Johan ;
Verhaegen, Jan ;
Verbeken, Eric ;
De Munter, Paul ;
Meersseman, Wouter ;
Van Meensel, Britt ;
Van Eldere, Johan ;
Lagrou, Katrien .
JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (12) :3871-3874
[3]  
HELD J, 2010, CLIN MICROB IN PRESS
[4]   Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study [J].
Helweg-Larsen, Jannik ;
Benfield, Thomas ;
Atzori, Chiara ;
Miller, Robert F. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (06) :1282-1290
[5]   Pneumocystis jirovecii dihydropteroate synthase gene mutations and human immunodeficiency virus-associated Pneumocystis pneumonia [J].
Huang, Laurence ;
Welsh, David A. ;
Miller, Robert F. ;
Ben Beard, C. ;
Lawrence, Gena G. ;
Fox, Melissa ;
Swartzman, Alexandra ;
Bensley, Matthew R. ;
Carbonnet, Denise ;
Davis, J. Lucian ;
Chi, Amy ;
Yoo, Becky J. ;
Jones, Jeffrey L. .
JOURNAL OF EUKARYOTIC MICROBIOLOGY, 2006, 53 :S114-S116
[6]   FALSE-POSITIVE RESULT IN LIMULUS TEST CAUSED BY LIMULUS AMEBOCYTE LYSATE-REACTIVE MATERIAL IN IMMUNOGLOBULIN PRODUCTS [J].
IKEMURA, K ;
IKEGAMI, K ;
SHIMAZU, T ;
YOSHIOKA, T ;
SUGIMOTO, T .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (09) :1965-1968
[7]   Influence of various hemodialysis membranes on the plasma (1→3)-β-D-glucan level [J].
Kanda, H ;
Kubo, K ;
Hamasaki, K ;
Kanda, Y ;
Nakao, A ;
Kitamura, T ;
Fujita, T ;
Yamamoto, K ;
Mimura, T .
KIDNEY INTERNATIONAL, 2001, 60 (01) :319-323
[8]   Detection of Pneumocystis carinii DNA in patients with chronic lung diseases [J].
Probst, M ;
Ries, H ;
Schmidt-Wieland, T ;
Serr, A .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2000, 19 (08) :644-645
[9]   Difficulties in using 1,3-β-D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies - high frequency of false-positive results and their analysis [J].
Racil, Zdenek ;
Kocmanova, Iva ;
Lengerova, Martina ;
Weinbergerova, Barbara ;
Buresova, Lucie ;
Toskova, Martina ;
Winterova, Jana ;
Timilsina, Shira ;
Rodriguez, Isa ;
Mayer, Jiri .
JOURNAL OF MEDICAL MICROBIOLOGY, 2010, 59 (09) :1016-1022
[10]   Positive (1→3)-β-D-glucan in blood components and release of (1→3)-β-D-glucan, from depth-type membrane filters for blood processing [J].
Usami, M ;
Ohata, A ;
Horiuchi, T ;
Nagasawa, K ;
Wakabayashi, T ;
Tanaka, S .
TRANSFUSION, 2002, 42 (09) :1189-1195